首页> 美国卫生研究院文献>Clinical Kidney Journal >Calciphylaxis in a dialysis patient treated by intralesional and systemic sodium thiosulphate on top of multifactorial intervention
【2h】

Calciphylaxis in a dialysis patient treated by intralesional and systemic sodium thiosulphate on top of multifactorial intervention

机译:在病因内和全身应用硫代硫酸钠治疗的透析患者中​​进行钙化预防

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Calciphylaxis, or calcific uraemic arteriolopathy (CUA), represents a life-threatening disease. Dialysis patients and those receiving warfarin are seen as populations at higher risk for CUA. Treatments for CUA are still uncertain despite the poor survival of the disease. Administration of intravenous sodium thiosulphate (STS) has been purposed to treat CUA in dialysis patients. Due to the poor tolerability of STS, characterized by nausea, hypocalcaemia, metabolic acidosis and QT-interval prolongation, its intralesional administration has been reported. We herein present the improvement of wounds in a haemodialysis patient affected by CUA, treated by multipronged intervention including both intravenous and intralesional STS.
机译:钙化病或钙化性尿毒症动脉病(CUA)代表着威胁生命的疾病。透析患者和接受华法林的患者被视为罹患CUA的风险较高。尽管该病生存率低,但CUA的治疗仍不确定。静脉内注射硫代硫酸钠(STS)的目的是治疗透析患者的CUA。由于STS的耐受性差,表现为恶心,低血钙,代谢性酸中毒和QT间隔延长,因此已报告了其病灶内给药。我们在本文中介绍了受CUA影响的血液透析患者伤口的改善情况,采用多管齐下的干预措施(包括静脉内和病灶内STS)进行治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号